Literature DB >> 26387957

PI3K-C2α Knockdown Results in Rerouting of Insulin Signaling and Pancreatic Beta Cell Proliferation.

Barbara Leibiger1, Tilo Moede1, Meike Paschen1, Na-Oh Yunn2, Jong Hoon Lim3, Sung Ho Ryu4, Teresa Pereira1, Per-Olof Berggren5, Ingo B Leibiger6.   

Abstract

Insulin resistance is a syndrome that affects multiple insulin target tissues, each having different biological functions regulated by insulin. A remaining question is to mechanistically explain how an insulin target cell/tissue can be insulin resistant in one biological function and insulin sensitive in another at the same time. Here, we provide evidence that in pancreatic β cells, knockdown of PI3K-C2α expression results in rerouting of the insulin signal from insulin receptor (IR)-B/PI3K-C2α/PKB-mediated metabolic signaling to IR-B/Shc/ERK-mediated mitogenic signaling, which allows the β cell to switch from a highly glucose-responsive, differentiated state to a proliferative state. Our data suggest the existence of IR-cascade-selective insulin resistance, which allows rerouting of the insulin signal within the same target cell. Hence, factors involved in the rerouting of the insulin signal represent tentative therapeutic targets in the treatment of insulin resistance.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26387957     DOI: 10.1016/j.celrep.2015.08.058

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  16 in total

1.  Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.

Authors:  Prapaporn Jungtrakoon; Jun Shirakawa; Patinut Buranasupkajorn; Manoj K Gupta; Dario F De Jesus; Marcus G Pezzolesi; Aussara Panya; Timothy Hastings; Chutima Chanprasert; Christine Mendonca; Rohit N Kulkarni; Alessandro Doria
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

2.  Long-term c-Kit overexpression in beta cells compromises their function in ageing mice.

Authors:  Amanda Oakie; Zhi-Chao Feng; Jinming Li; Jenna Silverstein; Siu-Pok Yee; Rennian Wang
Journal:  Diabetologia       Date:  2019-06-01       Impact factor: 10.122

Review 3.  Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases.

Authors:  Jingping Hu; Mao Ye; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2016-11-15       Impact factor: 4.599

4.  An Overview of Class II Phosphoinositide 3-Kinases.

Authors:  Emily Yan Zhi Heng; Tania Maffucci
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 5.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

Review 6.  Replicative capacity of β-cells and type 1 diabetes.

Authors:  Diane Saunders; Alvin C Powers
Journal:  J Autoimmun       Date:  2016-04-28       Impact factor: 7.094

7.  Non-invasive cell type selective in vivo monitoring of insulin resistance dynamics.

Authors:  Meike Paschen; Tilo Moede; Barbara Leibiger; Stefan Jacob; Galyna Bryzgalova; Ingo B Leibiger; Per-Olof Berggren
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

8.  PI3 kinases p110α and PI3K-C2β negatively regulate cAMP via PDE3/8 to control insulin secretion in mouse and human islets.

Authors:  Jelena Kolic; Jocelyn E Manning Fox; Oleg G Chepurny; Aliya F Spigelman; Mourad Ferdaoussi; Frank Schwede; George G Holz; Patrick E MacDonald
Journal:  Mol Metab       Date:  2016-05-11       Impact factor: 7.422

9.  PI3K-C2α knockdown decreases autophagy and maturation of endocytic vesicles.

Authors:  Nathan M Merrill; Joshua L Schipper; Jonathan B Karnes; Audra L Kauffman; Katie R Martin; Jeffrey P MacKeigan
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

10.  Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.

Authors:  Samira Alliouachene; Benoit Bilanges; Claire Chaussade; Wayne Pearce; Lazaros C Foukas; Cheryl L Scudamore; Larissa S Moniz; Bart Vanhaesebroeck
Journal:  Diabetologia       Date:  2016-04-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.